Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages

Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages

Diabetes mellites (DM) is correlated with increased susceptibility to and disease progression of tuberculosis (TB), and strongly impairs effective global TB control measures. To better control the TB-DM co-epidemic, unravelling the bidirectional interactivity between DM-associated molecular processe...

Full description

Bibliographic Details
Main Authors:	Cassandra L. R. van Doorn, Sanne A. M. Steenbergen, Kimberley V. Walburg, Tom H. M. Ottenhoff
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Immunology
Subjects:	tuberculosis host-directed therapy poly (ADP-ribose) polymerase rucaparib human macrophages
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.712021/full

Similar Items

Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
by: Daniel Harrision, et al.
Published: (2020-08-01)

Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
by: Emad Matanes, et al.
Published: (2021-10-01)

Fused in Sarcoma (FUS) in DNA Repair: Tango with Poly(ADP-ribose) Polymerase 1 and Compartmentalisation of Damaged DNA
by: Maria V. Sukhanova, et al.
Published: (2020-09-01)

Poly(ADP-ribose) Polymerase 1 Mediates Rab5 Inactivation after DNA Damage
by: Masato Mashimo, et al.
Published: (2022-07-01)

Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase
by: Divakar Vishwanath, et al.
Published: (2022-01-01)

Changes in NAD/ADP-ribose metabolism in rectal cancer
by: L. Yalcintepe, et al.
Published: (2005-03-01)

Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy
by: Bijay Singh, et al.
Published: (2020-11-01)

Lipoic Acid Decreases the Expression of Poly ADP-Ribose Polymerase and Inhibits Apoptosis in Diabetic Rats
by: Chen J, et al.
Published: (2020-05-01)

Effect and Mechanism of Radiosensitization of Poly (ADP-Ribose) Polymerase  Inhibitor on Lewis Cells and Xenografts
by: Wei WANG, et al.
Published: (2016-01-01)

Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1
by: Konstantin N. Naumenko, et al.
Published: (2020-09-01)

Inhibition of Poly(ADP-Ribose) Polymerase Increased Lipid Accumulation Through SREBP1 Modulation
by: Jing Pang, et al.
Published: (2018-08-01)

PROTEOLYTIC DEGRADATION OF POLY (ADP-RIBOSE) POLYMERASE IN RATS WITH CARRAGEENAN-INDUCED GASTROENTEROCOLITIS
by: Tkachenko A. S., et al.
Published: (2017-12-01)

Investigation of the three-dimensional structure and interaction mechanism of poly (ADP-ribose) polymerase 4
by: Ayhan Ünlü, et al.
Published: (2020-01-01)

Involvement of poly(ADP-ribose) polymerase-1 in development of spinal cord injury in Chinese individuals: a Chinese clinical study
by: Meng Q, et al.
Published: (2017-12-01)

Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer
by: Ruihong Dong, et al.
Published: (2023-06-01)

Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins
by: Garri Manasaryan, et al.
Published: (2021-03-01)

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
by: Stephen A. Jannetti, et al.
Published: (2020-03-01)

Poly(ADP-Ribose) Polymerase 1 Promotes Inflammation and Fibrosis in a Mouse Model of Chronic Pancreatitis
by: Tarek El-Hamoly, et al.
Published: (2021-03-01)

Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials
by: Gartrell C. Bowling, et al.
Published: (2023-10-01)

Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo
by: Sridevi Challa, et al.
Published: (2022-04-01)

Poly(ADP-ribose) polymerase inhibition reveals a potential mechanism to promote neuroprotection and treat neuropathic pain
by: Prashanth Komirishetty, et al.
Published: (2016-01-01)

Inhibiting poly(ADP-ribosylation) improves axon regeneration
by: Alexandra B Byrne, et al.
Published: (2016-10-01)

Role of poly (ADP-ribose) polymerase-1 and cytokines in acute renal injury in elderly Chinese patients with diabetes mellitus
by: Cao L, et al.
Published: (2017-11-01)

ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control
by: Palmiro Poltronieri, et al.
Published: (2021-10-01)

Active Targeted Nanoparticles for Delivery of Poly(ADP-ribose) Polymerase (PARP) Inhibitors: A Preliminary Review
by: Saman Sargazi, et al.
Published: (2021-09-01)

New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage
by: Zongying Gu, et al.
Published: (2019-08-01)

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer
by: Goldie Y.L. Lui, et al.
Published: (2020-10-01)

Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy
by: Thomas Helleday, et al.
Published: (2012-12-01)

Influence of poly(ADP-ribose)polymerase inhibitors on some parameters of oxidative stress in blood leukocytes of rats with experimental diabetes
by: M. M. Guzyk, et al.
Published: (2013-02-01)

Poly (ADP-ribose) polymerase plays an important role in intermittent hypoxia-induced cell death in rat cerebellar granule cells
by: Chiu Sheng-Chun, et al.
Published: (2012-03-01)

In Vivo Level of Poly(ADP-ribose)
by: Masanao Miwa, et al.
Published: (2018-05-01)

Streptavidin-Conjugated DNA for the Boronate Affinity-Based Detection of Poly(ADP-Ribose) Polymerase-1 with Improved Sensitivity
by: Fengli Gao, et al.
Published: (2023-07-01)

The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity
by: Levente Kiss, et al.
Published: (2005-03-01)

Molecular Insights into Poly(ADP-ribose) Recognition and Processing
by: Ivan Ahel, et al.
Published: (2012-12-01)

High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis
by: Nishant Thakur, et al.
Published: (2021-11-01)

Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1<i>H</i>-benzo[d]imidazole-4-carboxamide: A Potent Poly(ADP-ribose) Polymerase (PARP) Inhibitor for Treatment of Cancer
by: Rui Min, et al.
Published: (2019-05-01)

Targeted therapy with Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of solid tumours
by: Faustyna Piędel, et al.
Published: (2020-03-01)

Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA Mutations
by: Qin Xu, et al.
Published: (2021-11-01)

Reduced Colonic Mucosal Injury in 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-Dioxin Poly ADP-Ribose Polymerase (TIPARP/PARP7)-Deficient Mice
by: David Hutin, et al.
Published: (2022-01-01)

Automodified Poly(ADP-Ribose) Polymerase Analysisto Monitor DNA Damagein Peripheral Lymphocytes of Floriculturists Occupationally Exposed to Pesticides
by: Serena Imperato, et al.
Published: (2019-02-01)